Terms: = Liver cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Staging
546 results:
1. SPC25 as a novel therapeutic and prognostic biomarker and its association with glycolysis, ferroptosis and ceRNA in lung adenocarcinoma.
Liu XS; Zhang Y; Ming X; Hu J; Chen XL; Wang YL; Zhang YH; Gao Y; Pei ZJ
Aging (Albany NY); 2024 Jan; 16(1):779-798. PubMed ID: 38217547
[TBL] [Abstract] [Full Text] [Related]
2. Alcohol-related cancer morbidity and mortality are stratified using modified albumin platelet product.
Fujita K; Morishita A; Oura K; Ono M; Himoto T; Masaki T
Sci Rep; 2024 Jan; 14(1):1052. PubMed ID: 38200049
[TBL] [Abstract] [Full Text] [Related]
3. Should lymphadenectomy performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysis.
Huang S; Song JL; Li B; Yi PS; Yang J
BMC Surg; 2023 Nov; 23(1):364. PubMed ID: 38036995
[TBL] [Abstract] [Full Text] [Related]
4. Fibroblast Activation Protein-Targeted PET/CT with
Xu W; Cai J; Peng T; Meng T; Pang Y; Sun L; Wu H; Zhang J; Chen X; Chen H
J Nucl Med; 2024 Jan; 65(1):40-51. PubMed ID: 37884330
[TBL] [Abstract] [Full Text] [Related]
5. Factors affecting overall survival and disease-free survival after surgery for hepatocellular carcinoma: a nomogram-based prognostic model-a Western European multicenter study.
Masuda Y; Yeo MHX; Burdio F; Sanchez-Velazquez P; Perez-Xaus M; Pelegrina A; Koh YX; Di Martino M; Goh BKP; Tan EK; Teo JY; Romano F; Famularo S; Ferrari C; Griseri G; Piardi T; Sommacale D; Gianotti L; Molfino S; Baiocchi G; Ielpo B
Updates Surg; 2024 Jan; 76(1):57-69. PubMed ID: 37839048
[TBL] [Abstract] [Full Text] [Related]
6. Effect of Peripheral Blood Lymphocytes on Prognosis of Multiple cancers.
Zhang X; Jing J
Cancer Control; 2023; 30():10732748231202921. PubMed ID: 37815060
[TBL] [Abstract] [Full Text] [Related]
7. The adherence to the American Association for the Study of liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival.
Manne A; Mulekar M; Escobar D; Prodduturvar P; Fahmawi Y; Henderson P; Abdul-Rahim O; Hussain Z; Liles S; Fonseca A; Howard JH; Mneimneh W; Gilbert R; Alkharabsheh O; Pai S; White ZB; Nelson C; Khushman M
J Cancer Res Ther; 2023; 19(5):1103-1108. PubMed ID: 37787270
[TBL] [Abstract] [Full Text] [Related]
8. cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.
He S; Xia C; Li H; Cao M; Yang F; Yan X; Zhang S; Teng Y; Li Q; Chen W
Sci China Life Sci; 2024 Jan; 67(1):122-131. PubMed ID: 37755589
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis.
Komiyama S; Okusaka T; Maruki Y; Ohba A; Nagashio Y; Kondo S; Hijioka S; Morizane C; Ueno H; Sukeda A; Mizui T; Takamoto T; Nara S; Ban D; Esaki M; Hiraoka N; Shimada K
Intern Med; 2024 Apr; 63(7):891-901. PubMed ID: 37612088
[TBL] [Abstract] [Full Text] [Related]
10. Modified integrated tumor burden, liver function, systemic inflammation, and tumor biology score to predict long-term outcomes after resection for hepatocellular carcinoma.
Endo Y; Moazzam Z; Alaimo L; Woldesenbet S; Lima HA; Munir MM; Katayama E; Yang J; Azap L; Shaikh CF; Ratti F; Marques HP; Cauchy F; Lam V; Poultsides GA; Kitago M; Popescu I; Alexandrescu S; Martel G; Guglielmi A; Gleisner A; Hugh T; Aldrighetti L; Shen F; Endo I; Pawlik TM
HPB (Oxford); 2023 Dec; 25(12):1484-1493. PubMed ID: 37544855
[TBL] [Abstract] [Full Text] [Related]
11. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study.
Huang J; Wang ZG; Tao QF; Yang Y; Yuan SX; Gu FM; Liu H; Pan ZY; Jiang BG; Lau WY; Zhou WP
Front Immunol; 2023; 14():1198562. PubMed ID: 37483609
[TBL] [Abstract] [Full Text] [Related]
13.
Kersting D; Sandach P; Sraieb M; Wiesweg M; Metzenmacher M; Darwiche K; Oezkan F; Bölükbas S; Stuschke M; Umutlu L; Nader M; Hamacher R; Fendler WP; Wienker J; Eberhardt WEE; Schuler M; Herrmann K; Hautzel H
J Nucl Med; 2023 Oct; 64(10):1540-1549. PubMed ID: 37474272
[TBL] [Abstract] [Full Text] [Related]
14. liver fibrosis quantified by image morphometry predicts clinical outcomes in patients with non-alcoholic fatty liver disease.
Wang Z; Jeffrey GP; Huang Y; De Boer B; Garas G; Wallace M; Bertot L; Adams LA
Hepatol Int; 2023 Oct; 17(5):1162-1169. PubMed ID: 37358741
[TBL] [Abstract] [Full Text] [Related]
15. A spliceosome-associated gene signature aids in predicting prognosis and tumor microenvironment of hepatocellular carcinoma.
Wang H; Wang R; Fang J
Aging (Albany NY); 2023 Jun; 15(11):4906-4925. PubMed ID: 37301543
[TBL] [Abstract] [Full Text] [Related]
16. Radiomics in colorectal cancer patients.
Inchingolo R; Maino C; Cannella R; Vernuccio F; Cortese F; Dezio M; Pisani AR; Giandola T; Gatti M; Giannini V; Ippolito D; Faletti R
World J Gastroenterol; 2023 May; 29(19):2888-2904. PubMed ID: 37274803
[TBL] [Abstract] [Full Text] [Related]
17. [Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases].
Lai YM; Li ZW; Li H; Wu Y; Shi YF; Zhou LX; Lou YT; Cui CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):262-269. PubMed ID: 37042136
[TBL] [Abstract] [Full Text] [Related]
18. A narrative review of intrahepatic cholangiocarcinoma: a surgical curative option.
Melandro F; Nasto RA; Ginesini M; Balzano E; Bindi ML; Ghinolfi D; Lai Q
Chin Clin Oncol; 2023 Apr; 12(2):13. PubMed ID: 37038053
[TBL] [Abstract] [Full Text] [Related]
19. Outcomes and survival in patients with advanced intestinal neuroendocrine tumours on home parenteral nutrition, an international multicentre retrospective cohort study.
Clement DSVM; Srirajaskanthan R; Ramage JK; Tesselaar MET; Khan MS; Verbeek WHM; Wanten GJA; Naghibi M
Clin Nutr ESPEN; 2023 Apr; 54():106-112. PubMed ID: 36963850
[TBL] [Abstract] [Full Text] [Related]
20. The COVID - AGICT study: COVID-19 and advanced gastro-intestinal cancer surgical treatment. A multicentric Italian study on the SARS-CoV-2 pandemic impact on gastro-intestinal cancers surgical treatment during the 2020. Analysis of perioperative and short-term oncological outcomes.
Giuliani G; Guerra F; Messinese S; Santelli F; Salvischiani L; Esposito S; Ferraro L; Esposito A; De Pastena M; Rega D; Delrio P; La Raja C; Spinelli A; Massaron S; De Nardi P; Kauffmann EF; Boggi U; Deidda S; Restivo A; Marano A; Borghi F; Piccoli M; Depalma N; D'Ugo S; Spampinato M; Cozzani F; Del Rio P; Marcellinaro R; Carlini M; De Rosa R; Scabini S; Maiello F; Polastri R; Turri G; Pedrazzani C; Zese M; Parini D; Casaril A; Moretto G; De Leo A; Catarci M; Trapani R; Zonta S; Marsanic P; Muratore A; Di Franco G; Morelli L; Coppola A; Caputo D; Andreuccetti J; Pignata G; Mastrangelo L; Jovine E; Mazzola M; Ferrari G; Mariani L; Ceccarelli G; Giuseppe R; Bolzon S; Grasso M; Testa S; Germani P; de Manzini N; Langella S; Ferrero A; Coletta D; Bianchi PP; Bengala C; Coratti A;
Surg Oncol; 2023 Apr; 47():101907. PubMed ID: 36924550
[TBL] [Abstract] [Full Text] [Related]
[Next]
